0_Web_Front page - SliderEuropeEurope.PortalSvet.Slajder

EU regulator backs AstraZeneca shot use despite blood clot link

Despite very rare cases of brain thrombosis linked to AstraZeneca's coronavirus jabs, the European Medicines Agency (EMA) has confirmed its recommendation of the use of the vaccine in all adults.

Brussels, 7 April 2021 (dpa/MIA) – Despite very rare cases of brain thrombosis linked to AstraZeneca’s coronavirus jabs, the European Medicines Agency (EMA) has confirmed its recommendation of the use of the vaccine in all adults.

Though unusual blood cots should be listed as a possible side effect, the benefits of the jab outweigh the risks, the EMA explained following a review of cases.

“Covid-19 is a very serious disease with a high hospitalization and death rate, and everyday covid is still causing thousands of deaths across the EU,” EMA director Emer Cooke said at a press conference.

The announcement confirms a previous assessment by the agency, which had deemed the vaccine safe and effective.

Таг
Back to top button
Close
Close